|
"lau c s"的相关文件
显示项目 1-4 / 4 (共1页)
1
每页显示[10|25|50]项目
| 國立成功大學 |
2023 |
Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis
|
Peng, K.;Blais, J.E.;Pratt, N.L.;Guo, J.J.;Hillen, J.B.;Stanford, T.;Ward, M.;Lai, E.C.-C.;Shin, J.-Y.;Tong, X.;Fan, M.;Cheng, F.W.T.;Wu, J.;Yeung, W.W.Y.;Lau, C.-S.;Leung, W.K.;Wong, I.C.K.;Li, X. |
| 國立成功大學 |
2023 |
Cardiovascular risk in rheumatoid arthritis patients treated with targeted synthetic and biological disease-modifying antirheumatic drugs: A multi-centre cohort study
|
Tong, X.;Shen, C.-Y.;Jeon, H.-L.;Li, Y.;Shin, J.-Y.;Chan, S.C.W.;Yiu, K.H.;Pratt, N.L.;Ward, M.;Lau, C.S.;Wong, I.C.K.;Li, X.;Lai, E.C.-C. |
| 國立成功大學 |
2022 |
Monoclonal antibodies and Fc-fusion protein biologic medicines: A multinational cross-sectional investigation of accessibility and affordability in Asia Pacific regions between 2010 and 2020
|
Tong, X.;Li, X.;Pratt, N.L.;Hillen, J.B.;Stanford, T.;Ward, M.;Roughead, E.E.;Lai, E.C.-C.;Shin, J.-Y.;Cheng, F.W.T.;Peng, K.;Lau, C.S.;Leung, W.K.;Wong, I.C.K. |
| 臺大學術典藏 |
2021-02-02T02:47:57Z |
Dosing down and then discontinuing biologic therapy in rheumatoid arthritis: A review of the literature
|
Chen D.-Y.; Lau C.S.; Elzorkany B.; PING-NING HSU; Praprotnik S.; Vasilescu R.; Marshall L.; Llamado L. |
显示项目 1-4 / 4 (共1页)
1
每页显示[10|25|50]项目
|
